Skip to main content

Advertisement

Table 4 Association between CRP levels and high MDA-LDL level in univariate and multivariate logistic analyses

From: Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease

  CRP concentration, mg/dL  
  <0.1 0.1–0.2 ≥0.2 p*
Univariate, OR (95% CI) 1 1.77 (0.89–3.55) 3.40 (1.54–8.02) 0.006
Multivariate, OR (95% CI)     
 Adjusted for LDL-C 1 1.43 (0.68–3.01) 3.44 (1.49–8.45) 0.014
 Adjusted for LDL-C, TG 1 1.08 (0.49–2.35) 2.74 (1.14–6.95) 0.071
 Adjusted for LDL-C, TG, HDL-C 1 0.95 (0.42–2.09) 2.41 (0.98–6.20) 0.124
  1. Abbreviations: CI confidence interval, CRP C-reactive protein, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, MDA-LDL malondialdehyde-modified LDL, OR odds ratio; TG triglycerides.
  2. Univariate and multivariate logistic analyses with an adjustment for the indicated parameters were performed. A high MDA-LDL level was defined by a median value of >91 U/L.
  3. *Likelihood ratio test for trend.